India must not depend on foreign AI models, as US export controls demonstrate potential access denial. Past reliance on external tech, like...

U.S. Stock Market today: Micron Technology shares ⁠moved higher in premarket trading on Monday. AI-driven optimism has supported Wall Stree...

Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...

Steel giant ArcelorMittal is joining forces with Amazon Web Services (AWS) to revolutionize its global operations. By integrating AWS's clo...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

Brokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...

Russia is eyeing India's burgeoning infrastructure, particularly its ports, for investments using accumulated rupee funds. Discussions are ...

In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

SBI Funds Management, India's largest mutual fund house, has secured SEBI's nod for its upcoming Initial Public Offering, expected to launc...

The carbon capture, utilisation and storage (CCUS) scheme is expected to attract investments of about ₹37,500 crore and create carbon-captu...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

Jubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...

Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...

Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Concord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...

Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...